 | • レポートコード：MRC2-11QY02431 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はANCA関連血管炎薬のグローバル市場について調査・分析したレポートです。種類別（ベリムマブ、CCX-1378、CCX-168、ダラザチド、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ANCA関連血管炎薬の競争状況、市場シェア ・世界のANCA関連血管炎薬市場：種類別市場規模 2015年-2020年（ベリムマブ、CCX-1378、CCX-168、ダラザチド、その他） ・世界のANCA関連血管炎薬市場：種類別市場規模予測 2021年-2026年（ベリムマブ、CCX-1378、CCX-168、ダラザチド、その他） ・世界のANCA関連血管炎薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のANCA関連血管炎薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のANCA関連血管炎薬市場分析：米国、カナダ ・ヨーロッパのANCA関連血管炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのANCA関連血管炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のANCA関連血管炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのANCA関連血管炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ChemoCentryx, Inc.、GlaxoSmithKline plc、Kineta, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anca Vasculitis Drug Market
The global Anca Vasculitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anca Vasculitis Drug Scope and Market Size
Anca Vasculitis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anca Vasculitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anca Vasculitis Drug market is segmented into
Belimumab
CCX-1378
CCX-168
Dalazatide
Others
Segment by Application, the Anca Vasculitis Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Anca Vasculitis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anca Vasculitis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anca Vasculitis Drug Market Share Analysis
Anca Vasculitis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anca Vasculitis Drug business, the date to enter into the Anca Vasculitis Drug market, Anca Vasculitis Drug product introduction, recent developments, etc.
The major vendors covered:
ChemoCentryx, Inc.
GlaxoSmithKline plc
Kineta, Inc.
…
1 Study Coverage
1.1 Anca Vasculitis Drug Product Introduction
1.2 Market Segments
1.3 Key Anca Vasculitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anca Vasculitis Drug Market Size Growth Rate by Type
1.4.2 Belimumab
1.4.3 CCX-1378
1.4.4 CCX-168
1.4.5 Dalazatide
1.4.6 Others
1.5 Market by Application
1.5.1 Global Anca Vasculitis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anca Vasculitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Anca Vasculitis Drug Revenue 2015-2026
2.1.2 Global Anca Vasculitis Drug Sales 2015-2026
2.2 Global Anca Vasculitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anca Vasculitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anca Vasculitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anca Vasculitis Drug Competitor Landscape by Players
3.1 Anca Vasculitis Drug Sales by Manufacturers
3.1.1 Anca Vasculitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Anca Vasculitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Anca Vasculitis Drug Revenue by Manufacturers
3.2.1 Anca Vasculitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Anca Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anca Vasculitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anca Vasculitis Drug Revenue in 2019
3.2.5 Global Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anca Vasculitis Drug Price by Manufacturers
3.4 Anca Vasculitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Anca Vasculitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anca Vasculitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Anca Vasculitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anca Vasculitis Drug Market Size by Type (2015-2020)
4.1.1 Global Anca Vasculitis Drug Sales by Type (2015-2020)
4.1.2 Global Anca Vasculitis Drug Revenue by Type (2015-2020)
4.1.3 Anca Vasculitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anca Vasculitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Anca Vasculitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Anca Vasculitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Anca Vasculitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anca Vasculitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anca Vasculitis Drug Market Size by Application (2015-2020)
5.1.1 Global Anca Vasculitis Drug Sales by Application (2015-2020)
5.1.2 Global Anca Vasculitis Drug Revenue by Application (2015-2020)
5.1.3 Anca Vasculitis Drug Price by Application (2015-2020)
5.2 Anca Vasculitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Anca Vasculitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Anca Vasculitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Anca Vasculitis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anca Vasculitis Drug by Country
6.1.1 North America Anca Vasculitis Drug Sales by Country
6.1.2 North America Anca Vasculitis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anca Vasculitis Drug Market Facts & Figures by Type
6.3 North America Anca Vasculitis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Anca Vasculitis Drug by Country
7.1.1 Europe Anca Vasculitis Drug Sales by Country
7.1.2 Europe Anca Vasculitis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anca Vasculitis Drug Market Facts & Figures by Type
7.3 Europe Anca Vasculitis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anca Vasculitis Drug by Region
8.1.1 Asia Pacific Anca Vasculitis Drug Sales by Region
8.1.2 Asia Pacific Anca Vasculitis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anca Vasculitis Drug Market Facts & Figures by Type
8.3 Asia Pacific Anca Vasculitis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anca Vasculitis Drug by Country
9.1.1 Latin America Anca Vasculitis Drug Sales by Country
9.1.2 Latin America Anca Vasculitis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anca Vasculitis Drug Market Facts & Figures by Type
9.3 Central & South America Anca Vasculitis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anca Vasculitis Drug by Country
10.1.1 Middle East and Africa Anca Vasculitis Drug Sales by Country
10.1.2 Middle East and Africa Anca Vasculitis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anca Vasculitis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Anca Vasculitis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 ChemoCentryx, Inc.
11.1.1 ChemoCentryx, Inc. Corporation Information
11.1.2 ChemoCentryx, Inc. Description and Business Overview
11.1.3 ChemoCentryx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Products Offered
11.1.5 ChemoCentryx, Inc. Related Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Corporation Information
11.2.2 GlaxoSmithKline plc Description and Business Overview
11.2.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline plc Anca Vasculitis Drug Products Offered
11.2.5 GlaxoSmithKline plc Related Developments
11.3 Kineta, Inc.
11.3.1 Kineta, Inc. Corporation Information
11.3.2 Kineta, Inc. Description and Business Overview
11.3.3 Kineta, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Kineta, Inc. Anca Vasculitis Drug Products Offered
11.3.5 Kineta, Inc. Related Developments
11.1 ChemoCentryx, Inc.
11.1.1 ChemoCentryx, Inc. Corporation Information
11.1.2 ChemoCentryx, Inc. Description and Business Overview
11.1.3 ChemoCentryx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Products Offered
11.1.5 ChemoCentryx, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anca Vasculitis Drug Market Estimates and Projections by Region
12.1.1 Global Anca Vasculitis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Anca Vasculitis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.2.2 North America: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anca Vasculitis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anca Vasculitis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anca Vasculitis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anca Vasculitis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anca Vasculitis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anca Vasculitis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anca Vasculitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anca Vasculitis Drug Market Segments
Table 2. Ranking of Global Top Anca Vasculitis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anca Vasculitis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Belimumab
Table 5. Major Manufacturers of CCX-1378
Table 6. Major Manufacturers of CCX-168
Table 7. Major Manufacturers of Dalazatide
Table 8. Major Manufacturers of Others
Table 9. Global Anca Vasculitis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Anca Vasculitis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Anca Vasculitis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Anca Vasculitis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Anca Vasculitis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Anca Vasculitis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Anca Vasculitis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Anca Vasculitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Anca Vasculitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anca Vasculitis Drug as of 2019)
Table 18. Anca Vasculitis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Anca Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Anca Vasculitis Drug Price (2015-2020) (USD/Pcs)
Table 21. Anca Vasculitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anca Vasculitis Drug Product Type
Table 23. Date of International Manufacturers Enter into Anca Vasculitis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Anca Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Anca Vasculitis Drug Sales Share by Type (2015-2020)
Table 27. Global Anca Vasculitis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Anca Vasculitis Drug Revenue Share by Type (2015-2020)
Table 29. Anca Vasculitis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Anca Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Anca Vasculitis Drug Sales Share by Application (2015-2020)
Table 32. North America Anca Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Anca Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Anca Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Anca Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Anca Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Anca Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Anca Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Anca Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Anca Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Anca Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Anca Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Anca Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Anca Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Anca Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Anca Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Anca Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Anca Vasculitis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Anca Vasculitis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Anca Vasculitis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Anca Vasculitis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Anca Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Anca Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Anca Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Anca Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Anca Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Anca Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Anca Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Anca Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Anca Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Anca Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Anca Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Anca Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Anca Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anca Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Anca Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anca Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Anca Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Application (2015-2020)
Table 72. ChemoCentryx, Inc. Corporation Information
Table 73. ChemoCentryx, Inc. Description and Major Businesses
Table 74. ChemoCentryx, Inc. Anca Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. ChemoCentryx, Inc. Product
Table 76. ChemoCentryx, Inc. Recent Development
Table 77. GlaxoSmithKline plc Corporation Information
Table 78. GlaxoSmithKline plc Description and Major Businesses
Table 79. GlaxoSmithKline plc Anca Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. GlaxoSmithKline plc Product
Table 81. GlaxoSmithKline plc Recent Development
Table 82. Kineta, Inc. Corporation Information
Table 83. Kineta, Inc. Description and Major Businesses
Table 84. Kineta, Inc. Anca Vasculitis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Kineta, Inc. Product
Table 86. Kineta, Inc. Recent Development
Table 87. Global Anca Vasculitis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 88. Global Anca Vasculitis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 89. Global Anca Vasculitis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 90. Global Anca Vasculitis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 91. North America: Anca Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. North America: Anca Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Europe: Anca Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 94. Europe: Anca Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Asia Pacific: Anca Vasculitis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 96. Asia Pacific: Anca Vasculitis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 97. Latin America: Anca Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Latin America: Anca Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Middle East and Africa: Anca Vasculitis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. Middle East and Africa: Anca Vasculitis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key Anca Vasculitis Drug Players
Table 105. Anca Vasculitis Drug Customers List
Table 106. Anca Vasculitis Drug Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Anca Vasculitis Drug Product Picture
Figure 2. Global Anca Vasculitis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Belimumab Product Picture
Figure 4. CCX-1378 Product Picture
Figure 5. CCX-168 Product Picture
Figure 6. Dalazatide Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anca Vasculitis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Anca Vasculitis Drug Report Years Considered
Figure 13. Global Anca Vasculitis Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Anca Vasculitis Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Anca Vasculitis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Anca Vasculitis Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Anca Vasculitis Drug Sales Market Share by Region in 2019
Figure 18. Global Anca Vasculitis Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Anca Vasculitis Drug Revenue Market Share by Region in 2019
Figure 20. Global Anca Vasculitis Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Anca Vasculitis Drug Revenue in 2019
Figure 22. Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Anca Vasculitis Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Anca Vasculitis Drug Sales Market Share by Type in 2019
Figure 25. Global Anca Vasculitis Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Anca Vasculitis Drug Revenue Market Share by Type in 2019
Figure 27. Global Anca Vasculitis Drug Market Share by Price Range (2015-2020)
Figure 28. Global Anca Vasculitis Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Anca Vasculitis Drug Sales Market Share by Application in 2019
Figure 30. Global Anca Vasculitis Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Anca Vasculitis Drug Revenue Market Share by Application in 2019
Figure 32. North America Anca Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Anca Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Anca Vasculitis Drug Sales Market Share by Country in 2019
Figure 35. North America Anca Vasculitis Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Anca Vasculitis Drug Market Share by Type in 2019
Figure 41. North America Anca Vasculitis Drug Market Share by Application in 2019
Figure 42. Europe Anca Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Anca Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Anca Vasculitis Drug Sales Market Share by Country in 2019
Figure 45. Europe Anca Vasculitis Drug Revenue Market Share by Country in 2019
Figure 46. Germany Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Anca Vasculitis Drug Market Share by Type in 2019
Figure 57. Europe Anca Vasculitis Drug Market Share by Application in 2019
Figure 58. Asia Pacific Anca Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Anca Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Anca Vasculitis Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Anca Vasculitis Drug Revenue Market Share by Region in 2019
Figure 62. China Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Anca Vasculitis Drug Market Share by Type in 2019
Figure 85. Asia Pacific Anca Vasculitis Drug Market Share by Application in 2019
Figure 86. Latin America Anca Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Anca Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Anca Vasculitis Drug Sales Market Share by Country in 2019
Figure 89. Latin America Anca Vasculitis Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Anca Vasculitis Drug Market Share by Type in 2019
Figure 97. Latin America Anca Vasculitis Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Anca Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Anca Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Anca Vasculitis Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Anca Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Anca Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Anca Vasculitis Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Anca Vasculitis Drug Market Share by Application in 2019
Figure 110. North America Anca Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Anca Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Anca Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Anca Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Anca Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Anca Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Anca Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Anca Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Anca Vasculitis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Anca Vasculitis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
血管炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Vasculitis Drug Market The global Vasculitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vasculitis Drug Scope and Market Size Vasculitis Drug market is segmented by Type, …- 血管炎治療の世界市場（～2026年） Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow -- even to the point of closing entirely. Vasculitis can affect people of all ages, but there are types of va…
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…